A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo-Reference-Cited by-同舟云学术

A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo

Published:1997-09 Issue:1-2 Volume:78 Page:34-46
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Ashley David M,Sampson John H,Archer Gary E,Batra Surinder K,Bigner Darell D,Hale Laura P

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference76 articles.

1. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: Rearrangement of heavy but not light chain genes;Alt;Cell,1981

2. Cross-priming of minor histocompatibility antigen-specific cytotoxic T-cells upon immunization with the heat shock protein gp96;Arnold;J. Exp. Med.,1995

3. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene;Batra;Cell Growth Differ.,1995

4. Oncogenes and anti-oncogenes in human central nervous system tumors;Batra;Lab. Invest.,1994

5. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay;Bevan;J. Exp. Med.,1976

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity;PLOS ONE;2019-01-02

2. Selecting an Optimal Antibody for Antibody- Drug Conjugate Therapy;Antibody-Drug Conjugates;2015

3. Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment;Current Signal Transduction Therapy;2012-01-01

4. Erlotinib in Glioblastoma - Lost in Translation?;Anti-Cancer Agents in Medicinal Chemistry;2011-10-01

5. Innovative Therapies against Human Glioblastoma Multiforme;ISRN Oncology;2011-07-24